Internal Medicine, Rheumatology · Cincinnati, OH
NPI
1023073905
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2123 Auburn Ave, Ste 630
Cincinnati, OH, 45219
Phone (513) 585-1970
Groups this clinician bills Medicare through
Medicare paid, 2024
$187K
12,979 services
Medicare patients, 2024
295
Average age 71
Drug cost, 2024
$2.3M
4,233 prescriptions
Company payments, 2025
$43.25
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yolanda D Farhey was code J1602 (injection, golimumab, 1 mg, for intravenous use), 4,650 times for 16 patients. In total Yolanda D Farhey billed 12,979 services in 28 codes, and Medicare paid $187K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-08-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 4,650 | 16 | $9.32 | $43K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 1,610 | 21 | $24.85 | $40K |
| 99214 Office E&M - Established | Office | 447 | 224 | $69.28 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 306 | 201 | $12.13 | $3,711 |
| 96413 Chemotherapy Administration | Office | 39 | 27 | $78.30 | $3,054 |
| 96415 Chemotherapy Administration | Office | 35 | 23 | $17.17 | $601 |
| 96365 Intravenous Infusion, Hydration | Office | 34 | 26 | $33.33 | $1,133 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 31 | 21 | $0.50 | $15.58 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 24 | 15 | $0.96 | $23.04 |
| 99205 Office E&M - New | Office | 23 | 23 | $120.64 | $2,775 |
| 99214 Office E&M - Established | Facility | 20 | 18 | $69.84 | $1,397 |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 20 | 18 | $2.09 | $41.84 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 13 | 12 | $12.49 | $162 |
By year: 2022 $307K for 13,657 services; 2023 $343K for 18,940 services; 2024 $187K for 12,979 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yolanda D Farhey prescribed most often to Medicare patients was Duloxetine Hcl, with 661 prescriptions and refills. In total Yolanda D Farhey wrote 4,233 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Duloxetine Hcl Generic | 661 | 1,276 | 141 | $15K |
| Gabapentin Generic | 477 | 792 | 123 | $6,986 |
| Hydroxychloroquine Sulfate Generic | 406 | 782 | 122 | $16K |
| Methotrexate Methotrexate Sodium | 391 | 711 | 106 | $9,511 |
| Pregabalin Generic | 321 | 494 | 79 | $14K |
| Prednisone Generic | 152 | 170 | 50 | $870 |
| Celecoxib Generic | 139 | 219 | 45 | $5,909 |
| Diclofenac Sodium Generic | 130 | 213 | 60 | $8,108 |
| Enbrel Sureclick Etanercept | 112 | 114 | 13 | $846K |
| Cyclobenzaprine Hcl Generic | 79 | 130 | 27 | $751 |
| Meloxicam Generic | 75 | 134 | 27 | $133 |
| Humira(Cf) Pen Adalimumab | 69 | 69 | 11 | $482K |
| Nabumetone Generic | 62 | 108 | 22 | $661 |
| Alendronate Sodium Generic | 62 | 166 | 24 | $409 |
| Tramadol Hcl Generic | 58 | 58 | 13 | $383 |
Brand drugs: - claims; generic drugs: 3,842 claims; opioid claims: 69.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yolanda D Farhey $43.25 ($43.25 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $43.25.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $43.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.